Results 271 to 280 of about 126,447 (301)
Some of the next articles are maybe not open access.
Propranolol‐resistant infantile hemangioma successfully treated with sirolimus
Pediatric dermatology, 2020Infantile hemangiomas are the most common benign vascular tumors in childhood. Propranolol is the first‐line treatment for infantile hemangiomas, but failures may occur.
Victoria L Dávila-Osorio +4 more
semanticscholar +1 more source
Infantile and congenital hemangiomas
Seminars in Pediatric Surgery, 2014Infantile hemangiomas (IHs) are the most common benign vascular tumors of infancy. Since they predominantly involute without significant residua, the majority do not require treatment. Indications for intervention include ulceration, prevention of disfigurement, and impairment of function or vital structures.
Ilona J. Frieden, Marilyn G. Liang
openaire +2 more sources
Capillary hemangioma (infantile periocular hemangioma)
Survey of Ophthalmology, 1994Capillary hemangiomas are the most common orbital tumors in children. They typically arise early in life, grow rapidly during a proliferative phase and then slowly regress in an involutional phase. The tumors may present as small isolated lesions of minimal clinical significance or as large disfiguring masses that can cause visual impairment and ...
Barrett G. Haik +3 more
openaire +3 more sources
Evaluation of Clinical Properties and Treatment Responses of Infantile Hemangioma.
Journal of Drugs in Dermatology, 2020BACKGROUND Infantile hemangiomas are the most common vascular tumors in childhood. Although spontaneous regression is common; several infantile hemangioma patients need treatment due to possible morbidities.
Didem Yıldırımçakar +3 more
semanticscholar +1 more source
Ulcerated Infantile Hemangioma of the Hard Palate: Diagnostic Treatment With Oral Propranolol.
The Journal of craniofacial surgery (Print), 2020Infantile hemangiomas arising in the palate are rare. The authors describe a case of ulcerated infantile hemangioma of the hard palate with feeding difficulty.
K. Ishikawa +10 more
semanticscholar +1 more source
Complications of infantile hemangiomas
Clinics in Dermatology, 2014Most infantile hemangiomas have a spontaneous and uneventful involution and, hence, may be treated expectantly. Others, however, will present some complication along their evolution that may require prompt therapeutic interventions. Ulceration is the most common complication, and amblyopia is frequently associated with periocular tumors.
openaire +3 more sources
Congenital hemangiomas and infantile hemangioma: missing links
Journal of the American Academy of Dermatology, 2004Rapid postnatal growth and slow involution in childhood characterize the common infantile hemangioma. There are other rare vascular tumors that present fully grown at birth and behave quite differently, as designated by the acronyms: rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH).
John B. Mulliken, Odile Enjolras
openaire +2 more sources
Facial Plastic Surgery Clinics of North America, 2014
Management of infantile hemangiomas includes a combination of observation, medical therapy, laser treatments, and surgery. The nomenclature to describe these lesions has been standardized and should be adhered to. The goal of treatment is to obtain the best possible result commensurate with known developmental milestones.
openaire +3 more sources
Management of infantile hemangiomas includes a combination of observation, medical therapy, laser treatments, and surgery. The nomenclature to describe these lesions has been standardized and should be adhered to. The goal of treatment is to obtain the best possible result commensurate with known developmental milestones.
openaire +3 more sources
Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment.
Journal of American Academy of Dermatology, 2021A. R. Rodríguez Bandera +3 more
semanticscholar +1 more source
Response to propranolol in infantile hemangioma
Pediatrics International, 2016AbstractPropranolol, 2 mg/kg/day, is effective in the treatment of infantile hemangioma. We report the response to propranolol in infants with hemangioma at a dose of 1 mg/kg/day. Sixteen infants with newly diagnosed infantile hemangioma were given propranolol at a dose titrated from 0.5 mg/kg/day then increased to 1 or 2 mg/kg/day based on response to
Praguywan Kadegasem +5 more
openaire +3 more sources